Welcome to Coulter Partners Global (English)

22 October 2020

Top hires for VC & PE portfolio companies Q3-2020

Search Highlights

Recent top global hires for Venture Capital and Private Equity backed companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech.

This quarter’s successful placements include:

Function Focus area Location
CEO Vaccines UK
CEO Medical devices Germany
Chief Financial Officer (US-based) Rare diseases Denmark
Chief Financial Officer Medical devices US
VP Research Rare diseases UK
VP Discovery Cell therapy Singapore
VP Engineering Medical devices Switzerland
VP Business Development & Licensing US Genome editing Ireland
Head of Regulatory Affairs Diagnostics UK
Head of CMC Immuno-oncology Singapore
Head of US Sales & Business Development Recombinant products UK
Marketing Director APAC Surgical devices France
Site Leader Manufacturing Operations France CDMO US
Chair CNS diseases Belgium

Newly opened projects include:

Function Focus area Location
CEO Haemostasis therapeutics Netherlands
Chief Human Resources Officer Surgical implants US
Chief Business Officer CNS diseases US
Chief Scientific Officer Gene therapy UK
Chief Development Officer Vaccines Switzerland
Head of Growth/Chief Marketing Officer Digital health Germany
VP Business Development UK & Europe Drug delivery US
VP Industrial Operations Europe Consumer health US
VP Product Development Vaccines US
VP Commercial Europe In vitro diagnostic products Israel
VP Business Development US Oncology Singapore
Head of Data & Analytics Antibody therapeutics UK
Chair Drug delivery UK


A new version of Coulter Partners is available.